The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers

Journal of Nanoparticle Research

Volumn 15, Issue 5, 2013, Pages

  Thakur, Shrikant ^a   Tekade, Rakesh K ^b   Kesharwani, Prashant ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

Cancer; Cytotoxicity; Dendrimers; Hemolytic toxicity; PEG as spacer; PEGylation; Targeting

Indexed keywords

ALIPHATIC COMPOUNDS; CELL CULTURE; CHAIN LENGTH; CONTROLLED DRUG DELIVERY; CYTOTOXICITY; DENDRIMERS; DRUG PRODUCTS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; MOLECULAR BIOLOGY; MOLECULAR WEIGHT; NANOCONJUGATES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYETHYLENE GLYCOLS; POLYETHYLENES; SHIMS; TOXICITY; TUMORS;

ANTI-CANCER AGENTS; CANCER; PEGYLATION; POLY(PROPYLENE IMINE); RECEPTOR-MEDIATED ENDOCYTOSIS; SPACER CHAIN LENGTH; TARGETING; TRANSMISSION ELECTRON;

TARGETED DRUG DELIVERY;

DENDRIMER; DOCETAXEL; DRUG CARRIER; FOLIC ACID; MACROGOL; POLY(PROPYLENE IMINE); UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG RELEASE; DRUG TUMOR LEVEL; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84875932986     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-013-1625-2     Document Type: Article

References (62)

1. Agarwal A, Gupta U, Asthana A, Jain NK (2009) Dextran conjugated dendrtitic nanoconstructs as potential vectors for anti-cancer agent. Biomaterials 30:3588-3596
2. Agashe HB, Babbar AK, Jain S, Sharma RK, Mishra AK, Asthana A, Garg M, Dutta T, Jain NK (2007) Investigations on biodistribution of technetium-99 m-labeled carbohydrate-coated poly(propylene imine) dendrimers. Nanomedicine 3:120-127
3. Asthana A, Chauhan AS, Diwan PV, Jain NK (2005) Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient. AAPS PharmSciTech 6:E536-E542
4. Bhadra D, Bhadra S, Jain S, Jain NK (2003) A PEGylated dendritic nanoparticulate carrier of fluorouracil. Int J Pharm 25:7111-7124
5. Bhadra D, Bhadra S, Jain NK (2005) PEGylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether. J Pharm Sci 8:467-482
6. Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56:1649-1659
7. Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631-651
8. De Brabander-van Den Berg EMM, Meijer EW (1993) PPI dendrimers: large-scale synthesis by hetereogeneously catalyzed hydrogenations. Angew Chem Int Ed Engl 32:1308-1311
9. Dutta T, Jain NK (2007) Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim Biophys Acta 1770:681-686
10. Dutta T, Agashe HB, Garg M, Balakrishnan P, Kabra M, Jain NK (2007) Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro. J Drug Target 15:89-98
11. Dutta T, Garg M, Jain NK (2008) Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B. Vaccine 26:3389-3394
12. Gajbhiye V, Jain NK (2011) The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates. Biomaterials 32:6213-6225
13. Gajbhiye V, Kumar PV, Tekade RK, Jain NK (2007) Pharmaceutical and biomedical potential of PEGylated dendrimers. Curr Pharm Des 13:415-429
14. Goddard JM, Erickson D (2009) Bioconjugation techniques for microfluidic biosensors. Anal Bioanal Chem 394:469-479
15. Grabarek Z, Gergely J (1990) Zero-length crosslinking procedure with the use of active esters. Anal Biochem 185:131-135
16. Guillaudeu SJ, Fox ME, Haidar YM, Dy EE, Szoka FC, Fréchet JM (2008) PEGylated dendrimers with core functionality for biological applications. Bioconjug Chem 19:461-469
17. Gupta U, Agashe HB, Jain NK (2007) Polypropylene imine dendrimer mediated solubility enhancement: effect of pH and functional groups of hydrophobes. J Pharm Sci 10:358-367
18. Ho J, Al-Deen FM, Al-Abboodi A, Selomulya C, Xiang SD, Plebanski M, Forde GM (2011) N,N′-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier. Colloids Surf B Biointerfaces 83:83-90
19. Hwa KS, Hoon JJ, Joe CO, Gwan PT (2005) Folate receptor mediated intracellular protein delivery using PLL-PEG-FOL conjugate. J Control Rel 103:625-634
20. Jabr-Milane LS, Van Vlerken L, Yadav S, Amiji MM (2008) Multi-functional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev 34:592-602
21. Jain NK, Asthana A (2007) Dendritic systems in drug delivery applications. Expert Opin Drug Deliv 4:495-512
22. Kaminskas LM, Kelly BD, McLeod VM, Sberna G, Owen DJ, Boyd BJ, Porter CJ (2011) Characterization and tumour targeting of PEGylated polylysine dendrimers bearing doxorubicin via a pH labile linker. J Control Release 152:241-248
23. Kannan S, Kolhe P, Raykova V, Glibatec M, Kannan RM, Lieh-Lai M, Bassett D (2004) Dynamics of cellular entry and drug delivery by dendritic polymers into human lung epithelial carcinoma cells. J Biomatter Sci Polym Ed 15:311-330
24. Kesharwani P, Tekade RK, Gajbhiye V, Jain K, Jain NK (2011) Cancer targeting potential of some ligand anchored poly(propylene imine) dendrimers: a comparison. Nanomedicine 7:295-304
25. Kim Y, Klutz AM, Jacobson KA (2008) Systematic investigation of polyamidoamine dendrimers surface-modified with poly(ethylene glycol) for drug delivery applications: synthesis, characterization, and evaluation of cytotoxicity. Bioconjug Chem 19:1660-1672
26. Kingsley JD, Dou H, Morehead J, Rabinow B, Gendelman HE, Destache CJ (2006) Nanotechnology: a focus on nanoparticles as a drug delivery system. J Neuroimmune Pharmacol 1(340):350
27. Kobayashi H, Kawamoto S, Saga T, Sato N, Hiraga A, Ishimori T, Konishi J, To-Gashi K, Brechbiel MW (2001) Positive effects of polyethylene glycol conjugation to generation-4 polyamidoamine dendrimers as macromolecular MR contrast agents. Magn Reson Med 46:781-788
28. Kojima C, Regino C, Umeda Y, Kobayashi H, Kono K (2010) Influence of dendrimer generation and polyethylene glycol length on the biodistribution of PEGylated dendrimers. Int J Pharm 383:293-306
29. Kolhe P, Khandare J, Pillai O, Kannan S, Lai ML, Kannan RM (2006) Preparation, cellular transport, and activity of polyamidoamine based dendritic nanodevices with a high drug payload. Biomaterials 27:660-669
30. Konda SD, Wang S, Brechbiel M, Wiener EC (2002) Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts. Invest Radiol 37:199-204
31. Kumar PV, Asthana A, Dutta T, Jain NK (2006) Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers. J Drug Target 14:546-556
32. Kumar PV, Agashe H, Dutta T, Jain NK (2007) PEGylated dendritic architecture for development of a prolonged drug delivery system for an antitubercular drug. Curr Drug Deliv 1:11-19
33. Kwon GS, Okano T (1996) Polymeric micelles as new drug carriers. Adv Drug Deliv Rev 16:107-116
34. Lee RJ, Low PS (1995) Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1233:134-144
35. Lim J, Guo Y, Rostollan CL, Standfield J, Hsieh JT, Sun X, Simanek EE (2008) The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. Mol Pharm 5:540-547
36. Liu Y, Li K, Pan J, Liu B, Feng SS (2010) Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Biomaterials 31:330-338
37. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63
38. Nie S, Xing Y, Kim GJ, Simons JW (2007) Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257-288
39. Okuda T, Kawakami S, Akimoto N, Niidome T, Yamashita F, Hashida M (2006) PEGylated lysine dendrimers for tumor-selective targeting after intravenous injection in tumor-bearing mice. J Control Release 116:330-336
40. Patri AK, Majoros I, Baker JR (2002) Dendritic polymer macromolecular carriers for drug delivery. Curr Opin Chem Biol 6:466-471
41. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri AK, Thomas T, Mule J, Baker JR (2002) Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Pharm Res 19:1310-1316
42. Sabharanjak S, Mayor S (2004) Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev 56:1099-1109
43. Sideratou Z, Kontoyianni C, Drossopoulou GI, Paleos CM (2010) Synthesis of a folate functionalized PEGylated poly(propylene imine) dendrimer as prospective targeted drug delivery system. Bioorg Med Chem Lett 20:6513-6527
44. Singh P, Gupta U, Asthana A, Jain NK (2008) Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice. Bioconjug Chem 19:2239-2252
45. Singhai AK, Jain S, Jain NK (1997) Evaluation of an aqueous injection of Ketoprofen. Pharmazie 52:149-151
46. Sinha R, Kim GJ, Nie S, Shin DM (2006) Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 5:1909-1917
47. Stewart BW, Kleihues P (2003) World Cancer Report WHO. International Agency for Research on Cancer, IARC Press, Lyon, France
48. Sudimack J, Lee RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41:147-162
49. Tekade RK, Dutta T, Tyagi A, Bharti AC, Das BC, Jain NK (2008) Surface-engineered dendrimers for dual drug delivery: a receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 16:758-772
50. Tekade RK, Dutta T, Gajbhiye V, Jain NK (2009a) Exploring dendrimers towards dual-drug delivery: pH responsive simultaneous kinetics. J Microencapsul 26:287-296
51. Tekade RK, Kumar PV, Jain NK (2009b) Dendrimers in oncology: an expanding horizon. Chem Rev 109:49-87
52. Thomas TP, Majoros IJ, Kotlyar A, Kukowska-Latallo JF, Bielinska A, Myc A, Baker JR (2005) Targeting and inhibition of cell growth by an engineered dendritic nanodevice. J Med Chem 48:3729-3735
53. Tomalia DA (1996) Starburst dendrimers-nanoscopic supermolecules according dendritic rules and principles. Macromol Symp 101:243-255
54. Tomalia DA, Naylor AM, Goddard WA (1990) Starburst dendrimers: molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter. Angew Chem Int Ed Engl 29:138-175
55. Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H (2003) Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal. Cancer Sci 94:15-21
56. Wolinsky JB, Grinstaff MW (2008) Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev 60:1037-1055
57. Yang H, Stephanie T, Lopina ST (2003) Penicillin V-conjugated PEG-PAMAM star polymers. J Biomater Sci Polym 14:1043-1056
58. Zange R, Li Y, Kissel T (1998) Biocompatibility testing of ABA copolymers consisting of poly (l-lactic-co-glycolic acid) A blocks attached to a central poly (ethylene oxide) B block under in vitro conditions using different L929 mouse fibroblast cell culture models. J Control Release 56:249-258
59. Zhai G, Wu J, Xiang G, Mao W, Yu B, Li H, Piao L, Lee LJ, Lee RJ (2009) Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery. J Nanosci Nanotechnol 9:2155-2161
60. Zhao XF, Dong L, Zheng W (2011) PEGylated thermo sensitive poly(amidoamine) dendritic drug delivery systems. Int J Pharm 100:123-131
61. Zhou QS, Jiang XH, Yu JR, Li KJ (2006) Synthesis and characterization of PEG-scutellarin conjugates, a potential PEG ester prodrug for the oral delivery of scutellarin. Chin Chem Lett 1:85-88
62. Zhu S, Hong M, Tang G, Qian L, Lin J, Jiang Y, Pei Y (2010) Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. Biomaterials 31:1360-1371